Signaturefd LLC Boosts Stock Position in Align Technology, Inc. $ALGN

Signaturefd LLC increased its stake in Align Technology, Inc. (NASDAQ:ALGN) by 17.1% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 961 shares of the medical equipment provider’s stock after purchasing an additional 140 shares during the quarter. Signaturefd LLC’s holdings in Align Technology were worth $182,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of the stock. Redmond Asset Management LLC grew its position in shares of Align Technology by 2.0% during the first quarter. Redmond Asset Management LLC now owns 2,769 shares of the medical equipment provider’s stock valued at $440,000 after purchasing an additional 54 shares in the last quarter. Horizon Investments LLC increased its stake in Align Technology by 6.2% in the first quarter. Horizon Investments LLC now owns 1,018 shares of the medical equipment provider’s stock worth $162,000 after purchasing an additional 59 shares during the period. Washington Trust Advisors Inc. lifted its holdings in Align Technology by 5.2% during the 1st quarter. Washington Trust Advisors Inc. now owns 1,205 shares of the medical equipment provider’s stock valued at $191,000 after buying an additional 60 shares in the last quarter. Covestor Ltd boosted its holdings in shares of Align Technology by 18.8% in the first quarter. Covestor Ltd now owns 493 shares of the medical equipment provider’s stock valued at $78,000 after purchasing an additional 78 shares during the period. Finally, Farther Finance Advisors LLC increased its stake in shares of Align Technology by 42.2% during the second quarter. Farther Finance Advisors LLC now owns 310 shares of the medical equipment provider’s stock valued at $59,000 after buying an additional 92 shares during the period. 88.43% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

ALGN has been the subject of a number of recent research reports. Piper Sandler reduced their price objective on shares of Align Technology from $250.00 to $190.00 and set an “overweight” rating for the company in a research note on Thursday, July 31st. Zacks Research raised Align Technology from a “strong sell” rating to a “hold” rating in a research report on Tuesday. Mizuho set a $210.00 price objective on Align Technology in a research report on Thursday, July 31st. Stifel Nicolaus reduced their target price on shares of Align Technology from $275.00 to $200.00 and set a “buy” rating for the company in a report on Thursday, July 31st. Finally, Evercore ISI lifted their price objective on shares of Align Technology from $200.00 to $220.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 9th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $215.00.

Insider Activity

In related news, CEO Joseph M. Hogan acquired 7,576 shares of the firm’s stock in a transaction dated Friday, August 1st. The stock was acquired at an average price of $131.49 per share, with a total value of $996,168.24. Following the acquisition, the chief executive officer directly owned 184,945 shares in the company, valued at $24,318,418.05. This represents a 4.27% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 0.66% of the stock is currently owned by company insiders.

Align Technology Stock Performance

Shares of ALGN opened at $128.70 on Friday. The stock has a 50-day moving average of $141.67 and a two-hundred day moving average of $165.94. Align Technology, Inc. has a one year low of $122.00 and a one year high of $246.19. The stock has a market cap of $9.33 billion, a P/E ratio of 21.70, a P/E/G ratio of 1.44 and a beta of 1.70.

Align Technology (NASDAQ:ALGN) last issued its quarterly earnings results on Wednesday, July 30th. The medical equipment provider reported $2.49 EPS for the quarter, missing analysts’ consensus estimates of $2.57 by ($0.08). The firm had revenue of $1.01 billion for the quarter, compared to analyst estimates of $1.06 billion. Align Technology had a return on equity of 13.36% and a net margin of 11.04%.The business’s revenue was down 1.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.41 EPS. Align Technology has set its Q3 2025 guidance at EPS. Analysts predict that Align Technology, Inc. will post 7.98 EPS for the current fiscal year.

Align Technology declared that its board has authorized a share repurchase program on Tuesday, August 5th that allows the company to repurchase $200.00 million in shares. This repurchase authorization allows the medical equipment provider to reacquire up to 2% of its shares through open market purchases. Shares repurchase programs are often a sign that the company’s management believes its stock is undervalued.

Align Technology Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.